Navigation Links
Brazil Will Purchase Merck’s Antiretroviral If Price Not Lowere

Brazilian Health Minister Jose Gomes Temporao on Wednesday signed a decree declaring that the country would purchase from an India-based drug maker a generic version of Merck's// antiretroviral Efavirenz if the company does not offer the drug at a lower price.

According to the decree, Efavirenz is a "public interest" medicine. Temporao at a news conference said the country did not issue the decree "as a threat, nor to lower the price of other medicines, but to guarantee its program of attending (AIDS) patients." Brazil has given Merck seven days to negotiate a lower price for the drug.

According to the AP/Forbes, if the two sides do not agree on a lower price, Brazil could break Merck's patent of the drug by issuing a compulsory license to produce or purchase a lower-cost version of the drug.

World Trade Organization regulations allow governments to declare a "national emergency" and issue compulsory licenses on any grounds without consulting the foreign patent owner.

Merck spokesperson Amy Rose said the company "does not believe compulsory licensing is in the best interest of patients," adding that Merck is committed to reaching an agreement with Brazil. Brazil and Merck in November 2006 began negotiations over Efavirenz.

According to the AP/Forbes, Brazil called on Merck to provide the drug at 65 cents per 600 mg dose -- the same price the company charges the Thai government. At the time, Brazil was paying $1.59 per dose, according to the decree.

Merck offered to reduce the price of Efavirenz in Brazil by 2%, but the country rejected the offer. About 75,000 of the 180,000 HIV-positive Brazilians who receive access to no-cost antiretrovirals from the government use Efavirenz, according to the AP/Forbes.

Brazil in 2005 reached an agreement with Abbott Laboratories over the price of its antiretroviral Kaletra after the country said it would break the drug's patent if its price were not lowered.

Source-Kaiser Family Foundation/V
'"/>




Related medicine news :

1. Brazil & Kenya Seek Support For A New Resolution At WHO’s Annual Mee
2. Brazilian Women to Be Vaccinated To Prevent Uterine Cancer
3. Malaria and TB Kills Indian Kids in Brazil
4. 13,000 Cases of Dengue Found in Brazil in January
5. Down Syndrome Dolls in Brazil After Child Actors Success
6. Brazil’s Claim to Fame - Fat Women and Drunk Men, Survey Find
7. Brazilian Boost for Bird Flu Vaccines
8. Brazil Spider Offers Hope for Those Suffering from Erectile Dysfunction
9. Brazil Government In Contention With Merck Over Anti-AIDS Drug
10. The Risks Involved In Purchase Of Over The Counter Medications
11. Online Auction Results In Purchase of Chemicals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
(Date:6/24/2016)... ... 2016 , ... Today, MTI-GlobalStem, a provider of optimized transfection ... to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing System ... is a complete system for culturing and transfecting human pluripotent stem cells for ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
Breaking Medicine Technology: